Full text is available at the source.
Abstract
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) may slow gastric emptying, potentially serving as a biomarker for treatment response.
- GLP-1 RAs enhance insulin secretion and suppress glucagon release.
- These agents promote feelings of fullness (satiety).
- Delayed gastric emptying is being considered for predicting treatment response.
- Point-of-care gastric ultrasound (POCUS) provides a bedside method to assess gastric contents.
Simplified